Predict your next investment

Venture Capital
pertinence-invest.com

See what CB Insights has to offer

Investments

5

Portfolio Exits

1

About Pertinence Invest

Pertinence Invest is an investment company supporting the development of technological start-ups.

Pertinence Invest Headquarter Location

66, Boulevard Niels Bohr Centre d’Entreprise et d’Innovation

Villeurbanne, 69603,

France

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Pertinence Invest News

Mablink Bioscience Raises €4M in Seed Funding

Apr 27, 2021

Mablink Bioscience , a Lyon, France-based company developing antibody-drug conjugates (ADC), completed a €4M seed financing round. The round was led by Elaia Partners with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création. Led by Jean-Guillaume Lafay, CEO, Mablink Bioscience is a biopharmaceutical company which has developed PSARlink™, an innovative and hydrophilic drug-linker technology that brings improved pharmacological properties to antibody-drug conjugates. The company will use the proceeds of this financing to move forward its ADC pipeline. FinSMEs 27/04/2021

Pertinence Invest Investments

5 Investments

Pertinence Invest has made 5 investments. Their latest investment was in Mablink Bioscience as part of their Seed VC on April 4, 2021.

CBI Logo

Pertinence Invest Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/27/2021

Seed VC

Mablink Bioscience

$4.83M

Yes

3

6/2/2016

Seed

Subscribe to see more

$99M

Subscribe to see more

10

2/26/2015

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

7/31/2014

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2014

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2021

6/2/2016

2/26/2015

7/31/2014

1/1/2014

Round

Seed VC

Seed

Seed VC

Seed VC

Seed VC

Company

Mablink Bioscience

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$4.83M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

10

10

10

10

Pertinence Invest Portfolio Exits

1 Portfolio Exit

Pertinence Invest has 1 portfolio exit. Their latest portfolio exit was Mathym on August 06, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/6/2019

Acquired

3

Date

8/6/2019

Exit

Acquired

Companies

Valuation

Acquirer

Sources

3

Pertinence Invest Team

1 Team Member

Pertinence Invest has 1 team member, including former President, Nicolas Penet.

Name

Work History

Title

Status

Nicolas Penet

Crealys, Atos, and Philips

President

Former

Name

Nicolas Penet

Work History

Crealys, Atos, and Philips

Title

President

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.